Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis

Area of Science:

• Genetics
• Molecular Biology
• Pulmonary Medicine

Background:

• Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options.
• Telomere length and maintenance are crucial for cellular stability and preventing premature aging.
• POT1 (Protection Of Telomeres 1) is a key protein involved in telomere regulation.

Purpose of the Study:

• To identify genetic causes of familial idiopathic pulmonary fibrosis (IPF).
• To investigate the functional consequences of a novel POT1 mutation (p.L259S) in IPF pathogenesis.
• To explore potential therapeutic avenues for IPF based on POT1 dysfunction.

Main Methods:

• Exonic sequencing to identify mutations in familial IPF cases.
• Functional assays to assess POT1(L259S) protein activity in vitro.
• Analysis of patient-derived cells for telomere length, DNA damage, and senescence markers.

Main Results:

• A novel heterozygous POT1 p.(L259S) mutation was identified in an IPF family with short telomeres and genetic anticipation.
• The POT1(L259S) mutation impairs telomeric overhang binding, nuclear localization, telomerase regulation, and lagging strand DNA synthesis.
• Patient cells with the POT1(L259S) mutation exhibit telomere shortening, DNA damage, and premature senescence.

Conclusions:

• The POT1(L259S) mutation is a pathogenic driver of idiopathic pulmonary fibrosis.
• Dysfunctional POT1 protein leads to telomere instability and cellular senescence, contributing to IPF.
• Understanding POT1's role opens new possibilities for IPF gene therapy.